Delivery Order SPE2DB20D2104-SPE2DB25FMMYA

Award Date 4/8/25
Potential Completion Date 4/29/25
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a medical product, with a ceiling value of $4,687.18 and a completion date of February 4, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML, a specialty medical product, with a ceiling value of $27,183.48 and an ultimate completion date of July 23, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a medical product, with a ceiling value of $2,265.29 and a period of performance through January 4, 2024. The contract is a firm fixed price delivery order, with no set-aside designation indicated. AmerisourceBergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML, a medical product, with a ceiling value of $6,795.87 and a performance period through August 7, 2024. The contract is a firm fixed price delivery order, with no set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, with a ceiling value of $2,343.59 and a period of performance through March 7, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The contract has a ceiling value of $4,687.18 and a completion date of February 5, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,687.18, is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 1, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) the vendor holds with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,687.18 contract is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a specialty pharmaceutical product, with a period of performance through May 2, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,326.45, is for the supply of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of July 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a medical product, with a ceiling value of $7,030.77 and a period of performance through April 30, 2025. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMMYA
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML, a pharmaceutical product, with a ceiling value of $4,687.18 and a period of performance through April 29, 2025. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/8/25, 2:37 PM